Why Glutathione Levels May Decline While our bodies are excellent at making glutathione, we don't always have a surplus
Mutagenic deamination of cytosine residues in DNA
This pharmacokinetic reality drives the gradual dose escalation protocol and explains why rushing the process typically backfires
Decreased activity of the mitochondrial respiratory chain was reported in overweight/obese patients with NASH compared to controls [97, 98], and alterations in mitochondrial ultrastructure have been observed prior to NAFLD development in the Otsuka LongEvans Tokushima Fatty rat [99] as well as in patients with steatosis preceding progression to NASH [100]
As prescriptions for drugs like semaglutide and tirzepatide surge, attention is shifting from drug availability to a critical enabler the medical devices required to deliver these therapies safely, sustainably, and at scale. He mentions that prefilled and reusable injection pens have emerged as the preferred delivery method, offering precision, convenience, and improved patient adherence
